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ABSTRACT
Background and objective: Previous studies have
found evidence of an association between tuberculosis
and vitamin D deficiency (VDD). However, the associa-
tion between VDD and infection caused by non-
tuberculous mycobacteria (NTM) has never been
studied.This study evaluated the prevalence and sever-
ity of VDD in NTM lung disease and attempted to iden-
tify predictive factors.
Methods: Age- and sex-matched case-control study
was conducted to assess the prevalence and severity of
VDD in patients with NTM lung disease.
Results: After adjusting for potential confounding
factors, the adjusted mean serum level of 25-
hydroxyvitamin D (25(OH)D) levels was lower in 104
patients with NTM lung disease (10.7 ng/mL, 95% con-
fidence interval (CI) 4.5–16.8 ng/mL) than that of
312 controls (13.7 ng/mL, 95% CI 7.4–19.5 ng/mL)
(P = 0.012). Although the prevalence of VDD defined as
serum 25(OH)D level <20 ng/mL was not different,
severe VDDdefined as serum25(OH)D level <10 ng/mL
was more prevalent in patients (P < 0.001). In multi-
variate analysis, severe (but not mild) VDD was inde-
pendently associated with NTM lung disease (adjusted
odds ratio 3.9, 95% CI 1.9–8.5, P < 0.001).
Conclusions: Patients with NTM lung disease have a
high prevalence of severe VDD and VDDwas independ-
ently associated with NTM lung disease. Further
studies are needed to examine causality.
Key words: case-control study, Korea, Mycobacterium avium
complex, non-tuberculous mycobacteria, vitamin D.
Abbreviation: BMI, body mass index; CI, confidence interval;
NTM, non-tuberculous mycobacteria; VDD, vitamin D deficiency.
INTRODUCTION
The incidence of lung disease caused by non-
tuberculous mycobacteria (NTM) in human immu-
nodeficiency virus-negative patients has been
increasing worldwide.1,2 A substantial proportion of
these patients have no predisposing risk factors.1
Mycobacterium avium complex and M. abscessus
complex are well-known organisms that cause these
forms of NTM lung disease.3–8
NTM are ubiquitous in the environment, and expo-
sure to these organisms is inevitable. However,
disease is rare, which suggests that normal host
defence mechanisms are effective enough to prevent
infection.9 Therefore, otherwise healthy individuals
who develop NTM lung diseasemay have susceptibil-
ity factors thatmake themvulnerable to infections.10,11
Vitamin D has a critical role in the innate immune
system and appears to have an important role in pro-
tection against respiratory tract infections.12 Vitamin
D can play an important role as an immunomodula-
tor of the innate immune response against M. tuber-
culosis.13,14 Many epidemiological studies have found
evidence of an association between 25(OH) vitaminD
(25(OH)D) levels and tuberculosis,15–19 although some
discrepancies exist among studies.20–22 However, the
association between vitamin D deficiency (VDD) and
NTM infections has never been studied.
In this case-control study, we investigated the
prevalence and severity of VDD in patients with NTM
lung disease and compared them with controls
sourced from the fourth Korean National Health and
Nutrition Examination Survey in 2008.23
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SUMMARY AT A GLANCE
Many epidemiological studies have found evi-
dence of an association between tuberculosis and
vitamin D deficiency (VDD). However, the associa-
tion between VDD and infection caused by non-
tuberculous mycobacteria (NTM) has never been
studied. This case-control study showed that
patients with NTM lung disease have a high preva-
lence of severe VDD.
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METHODS
Consecutive patients with the nodular bronchiectatic
form of NTM lung disease who were diagnosed
between January 2008 and December 2008 were
enrolled in an ongoing prospective observational
cohort study to investigate NTM lung disease
(ClinicalTrials.gov Identifier: NCT00970801) at the
SamsungMedical Center (a 1961-bed referral hospital
in Seoul, Korea). All of the patients met diagnostic
criteria for NTM lung disease according to the guide-
lines of the American Thoracic Society1 and had char-
acteristic findings on high-resolution computed
tomography scans.24,25 The patients with concurrent
pulmonary tuberculosis were excluded. In addition,
immunocompromised patients were excluded. The
diagnosis was based on culture positivity from at least
two separate expectorated sputum samples in 86
patients (83%) and on bronchial washing or broncho-
alveolar lavage fluid culture positivity in the remain-
ing 18 patients (17%). Sputum smears and
mycobacterial cultures were performedwith standard
methods as described.26 NTM species were identified
using a polymerase chain reaction and restriction
length polymorphism method based on the rpoB
gene and confirmed using multilocus sequence
analysis based on hsp65, rpoB and 16S ribosomal RNA
fragments, as described previously.27–30 The aetiologi-
cal organisms were M. avium complex in 69 (66%)
patients (M. avium in 38 and M. intracellulare in 31)
and M. abscessus complex in 35 (34%) patients
(M. abscessus in 14 and M. massiliense in 21). The
study was approved by the Institutional Review Board
at our institution, and written informed consent was
obtained from each participant.
Peripheral blood was collected before the initiation
of antibiotic treatment, and serum was aliquoted and
stored at -80°C until analysis. The serum 25(OH)D
levels were measured in duplicate using an enzyme-
linked immunosorbent assay kit (Immundiagnostik
AG, Bensheim, Germany) following the manufactur-
er’s instructions. VDD was defined as a serum
25(OH)D level of less than 20 ng/mL.31 As a serum
25(OH)D level for VDD can be defined as either 10 or
20 ng/mL depending on the level that is defined as
normal,31,32 we classified VDD as mild VDD, for a
serum 25(OH)D level of 10–19 ng/mL, or severe VDD,
for a serum 25(OH)D level <10 ng/mL.
The control group was randomly selected from the
study group of the fourth Korean National Health and
Nutrition Examination Survey,23 andwasmatched in a
1:3 ratio for sex and age to ensure an adequate sample
size for detecting a 20% of difference with 95% of
chance. Serum 25(OH)D data were available for 3047
males and 3878 females aged 10 years and older.23
The data were compared using the Mann–Whitney
U-test for the continuous variables and a chi-squared
or Fisher’s exact test for categorical variables. A mul-
tiple linear regression model was used to adjust for
potential confounding factors in the relationship
between NTM lung disease and serum 25(OH)D level.
We adjusted for age, sex, body mass index (BMI), pre-
vious history of tuberculosis, smoking history and
comorbidities, including diabetes, chronic liver
disease and chronic kidney disease that have been
linked to an increased prevalence of VDD.31 In addi-
tion, multiple logistic regression model was used to
adjust for potential confounding factors described
earlier in the association between the severity of VDD
and the development of NTM lung disease, as meas-
ured by the estimated odds ratio with a 95% confi-
dence interval (CI).
To identify independent predicting factors associ-
ated with VDD and severe VDD in patient with NTM
lung disease, multiple logistic regression analysis was
used. Variables with P-values <0.25 in the univariable
analysis, and the a priori variables of age, sex, BMI
and previous history of tuberculosis were entered into
a multiple logistic regression model in which VDD
was the outcome variable. All tests were two-sided,
and a P-value <0.05 was considered significant. Data
were analysed using IBM SPSS Statistics 19.0 (IBM,
Chicago, IL, USA).
RESULTS
The baseline characteristics of the patients with NTM
lung disease and controls are presented in Table 1.
BMI among patient with NTM lung disease (median
Table 1 Baseline characteristics of the study participants
Variables NTM patients (n = 104) Controls (n = 312) P-value
Age, years 57 (50–65) 57 (50–65) NA
Gender, male 23 (22) 69 (22) NA
Body mass index (kg/m2) 20.6 (19.5–22.3) 23.9 (21.8–25.9) <0.001
Current smoker 1 (1) 40 (13) <0.001
Previous history of tuberculosis 35 (34) 38 (12) <0.001
Comorbidity
Diabetes 7 (7) 30 (10) 0.358
Chronic heart disease 12 (12) 8 (3) 0.001
Chronic liver disease 7 (7) 4 (1) 0.007
Chronic kidney disease 1 (1) 1 (0) 0.441
Values are expressed as medians (interquartile range) or frequencies (%).
NA, not applicable; NTM, non-tuberculous mycobacteria.
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20.6 kg/m2, interquartile range 19.5–22.3 kg/m2) was
significantly lower than that among controls (median
23.9 kg/m2, interquartile range 21.8–25.9 kg/m2,
P < 0.001). The prevalence of current smoking was
significantly higher in controls (13%) than in patients
with NTM lung disease (1%). Previous history of
tuberculosis wasmore common in patients withNTM
lung disease (34%) than in controls (12%, P < 0.001).
In addition, other comorbidities were also more
common in the patients (Table 1).
The median 25(OH)D level was 9.8 ng/mL (inter-
quartile range 4.6–18.6 ng/mL) in patients with NTM
lung disease versus 15.4 ng/mL in controls (inter-
quartile range 11.9–20.2 ng/mL, P < 0.001). Using the
criterion of <20 ng/mL, the prevalence of VDD overall
was not significantly different between the patients
(78%) and controls (74%, P = 0.433). However, the
prevalence of severeVDDwas greater among patients
(50%) than among the controls (14%, P < 0.001,
Fig. 1). On the contrary, the prevalence of mild VDD
was lesser among patient (28%) than among the con-
trols (60%, P < 0.001, Fig. 1). The prevalence of
vitamin D insufficiency and vitamin D sufficiency
between two groups was not statistically different
(P = 0.060 and P = 0.094, respectively).
The results of multivariate analysis with the multi-
ple linear regression model are presented in Table 2.
After adjusting for a priori variables of age, sex, BMI,
previous history of tuberculosis, smoking history and
comorbidities, including diabetes, chronic liver
disease and chronic kidney disease, the adjusted
mean of 25(OH)D levels was lower in patients with
NTM lung disease (10.346 ng/mL, 95% CI 4.167–
16.526 ng/mL) than that of the controls (13.049 ng/
mL, 95% CI 6.986–19.112 ng/mL) (P = 0.013).
The results of univariate and multivariate analyses
with multiple logistic regression model are presented
in Table 3. After adjusting for a priori variables of age,
sex, BMI, previous history of tuberculosis, smoking
history and comorbidities, including diabetes,
chronic liver disease and chronic kidney disease,
severe VDD was independently associated with NTM
lung disease (adjusted odds ratio 4.1, 95% CI 1.9–8.8,
P < 0.001). However, mild VDD was not associated
with NTM lung disease (adjusted odds ratio 0.6, 95%
CI 0.3–1.3, P = 0.186).
Univariable comparisons of the baseline character-
istics of the 104 patients with NTM lung disease
according to VDD status are presented in Table S1 in
the online supporting information. There was no sig-
nificant difference in age, BMI or previous history of
tuberculosis. However, male gender was more
common among patients withVDD (22/81, 27%) than
among patients without VDD (1/23, 4%, P = 0.022).
Figure 1 Prevalence of different degrees
of vitamin D deficiency (VDD) among
cases with non-tuberculous mycobacterial
lung disease and controls. The serum
25(OH)D levels were classified as follows:31
severe VDD (sVDD): less than 10 ng/mL;
mild VDD (mVDD): 10–19 ng/mL; vitamin D
insufficiency (VDI): 21–29 ng/mL; and
vitamin D sufficiency (VDS): 30 ng/mL or
greater. ( ) cases; ( ) controls.
Table 2 Multiple linear regression for potential explanatory variables of serum 25(OH)D level
Variables Coefficient (b) 95% CI P-value
Age, years 0.098 0.024 to 0.171 0.009
Gender, male -0.301 -2.348 to 1.746 0.773
Body mass index (kg/m2) -0.070 -0.332 to 0.193 0.603
Current smoker -0.299 -3.160 to 2.562 0.837
Previous history of tuberculosis -2.150 -4.361 to 0.060 0.057
Diabetes -1.994 -4.892 to 0.904 0.177
Chronic liver disease -0.540 -5.721 to 4.640 0.838
Chronic kidney disease -2.984 -14.843 to 8.874 0.621
NTM lung disease -2.703 -4.822 to -0.584 0.013
CI, confidence interval; NTM, non-tuberculous mycobacteria.
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The proportion of subjects with M. avium complex
lung disease was higher among patients with VDD
(59/81, 73%) than among patients without VDD (10/
23, 44%, P = 0.009). After adjusting for potential con-
founding factors,M. avium complex was significantly
associated with VDD (adjusted odds ratio 3.5, 95% CI
1.2–9.7, P = 0.025) (Table S2 in the online supporting
information). Predicting factors associated with
severe VDD were also evaluated. However, there was
no independent predicting factor associated with
severe VDD, although there was a trend of that
M. avium complex lung disease wasmore common in
patients with severe VDD (adjusted odds ratio 2.441,
95% CI 0.970–6.143, P = 0.058).
DISCUSSION
To our knowledge, this is the first study to evaluate the
prevalence and severity of VDD in patients with NTM
lung disease. The results of our case-control study
indicate that the median 25(OH)D levels for patients
with NTM lung disease are significantly lower than
are those of healthy controls. Although the prevalence
of VDD overall was not significantly different, severe
VDD was more prevalent in patients with NTM lung
disease than among controls. Additionally, we found
that M. avium complex infection was independently
associated with VDD in patients with NTM lung
disease.
The serum 25(OH)D level is the best indicator of
overall vitamin D status because this measurement
reflects total vitamin D from dietary intake and sun-
light exposure.31 Defining a level of serum 25(OH)D as
deficient or insufficient depends on the level that is
defined as normal, but currently, there is no consen-
sus on the optimal serum level of 25(OH)D.33 Because
there are no standard cut-offs, the definition of VDD
may affect estimates of its prevalence. Previously,
according to the World Health Organization, levels
below 10 ng/mLwere considered deficient, and levels
below 20 ng/mL were classified as insufficient.32
When that range was used, the prevalence of VDD
among our patients was 50%, which was significantly
higher than the prevalence of 14% among healthy
controls (P < 0.001). However, with the recent
changes as in the laboratory reference ranges, VDD is
defined by most experts as a serum 25(OH)D level of
less than 20 ng/mL.34–37With the use of this definition,
47–64% of Korean men and women are deficient in
vitamin D.23 This high level of VDD in the general
population might be a reason why the prevalence of
VDD among our patients with NTM lung disease was
not significantly different from the prevalence among
the age- and sex-matched controls. However, the
median level of serum 25(OH)D in patients with
NTM lung disease was significantly lower than that in
controls.
Although our data suggest a link betweenNTM lung
disease and low serum 25(OH)D levels, there are
many causes of VDD in the general population that
are not related to NTM infection.31 The prevalence of
VDD is particularly high in the elderly due to an age-
associated decline in cutaneous vitamin D produc-
tion and decreased dietary vitamin D intake.37 This
bias was excluded by using age-matched controls in
the comparison of serum 25(OH)D levels between the
patients and the controls, and was adjusted by multi-
variate analysis of the predicting factors for VDD in
the patients. In addition, BMI is inversely related to
the serum 25(OH)D level.37
Many case-control studies and a prospective cohort
study demonstrated that low vitamin D level is asso-
ciated with pulmonary tuberculosis.15–19 There are
good evidences to suggest that VDD compromises
cell-mediated immunity and increases susceptibility
to mycobacterial infection.12 Vitamin D is required for
an interferon-g-mediated pathway in macrophages
that leads to autophagy, phagosomal maturation and
other antimicrobial activities against M. tuberculosis
infection.38 However, some studies from Asian
countries like Indonesia, China and Korea did not
support the hypothesis that VDD predisposes to
tuberculosis.20–22 Discrepancies between these studies
Table 3 Univariable and multivariable analysis with logistic regression model for probability of non-tuberculous
mycobacterial lung disease
Variables
Univariable analysis Multivariable analysis
OR (95% CI) P-value Adjusted OR (95% CI) P-value
Age, years 1.000 (0.980–1.020) 1.000 1.006 (0.979–1.033) 0.663
Male gender 1.000 (0.586–1.707) 1.000 0.605 (0.278–1.318) 0.206
Body mass index (kg/m2) 0.650 (0.584–0.724) <0.001 0.658 (0.582–0.745) <0.001
Current smoker 0.065 (0.009–0.481) 0.007 0.012 (0.001–0.153) 0.001
Previous history of tuberculosis 3.617 (2.130–6.145) <0.001 1.969 (1.002–3.867) 0.049
Diabetes 0.671 (0.286–1.577) 0.360 0.597 (0.174–2.043) 0.411
Chronic liver disease 5.503 (1.577–19.197) 0.007 16.733 (2.152–130.126) 0.007
Chronic kidney disease 2.990 (0.185–48.238) 0.440 0.395 (0.008–18.771) 0.637
Vitamin D deficiency
Mild deficiency 0.543 (0.296–0.996) 0.048 0.620 (0.305–1.259) 0.186
Severe deficiency 4.259 (2.304–7.874) < 0.001 4.105 (1.922–8.770) < 0.001
CI, confidence interval; OR, odds ratio.
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may be due to the higher prevalence of VDD among
Asians.22
There are several limitations to our study. Because
this study was a case-control design, no causal infer-
ences could be made for the observed association
between VDD and NTM lung disease. Moreover, our
study was conducted at a single institute with rela-
tively small sample size, which may limit the general-
izability of our findings. Second, the data on other
causes of VDD including dietary intake, alcohol con-
sumption, exposure to sunlight and medications,31
which may have influenced the significance of our
findings, were not obtained. Finally, we did not ascer-
tain the seasons of blood sampling for 25(OH)D
measurement among cases and controls.
In conclusion, this case-control study showed that
patients with NTM lung disease have a high preva-
lence of severe VDD. Moreover, severe VDD was inde-
pendently associated with NTM lung disease after
adjustments for potential confounding factors.
Studies are needed to clarify if there is a causal asso-
ciation between VDD and NTM lung disease.
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